PK, Safety and Tolerability of Single and Multiple Doses of Oxfendazole Tablets (HELP-OFZ)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04920292 |
|
Recruitment Status :
Completed
First Posted : June 9, 2021
Last Update Posted : December 20, 2022
|
Sponsor:
Swiss Tropical & Public Health Institute
Collaborators:
Ifakara Health Institute
Drugs for Neglected Diseases
Information provided by (Responsible Party):
Swiss Tropical & Public Health Institute
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | November 7, 2022 |
| Actual Study Completion Date : | November 14, 2022 |